Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.3
2.8
Journals
Current Oncology
Announcements
share announcement

Announcements

29 March 2023
Current Oncology | Top Cited Papers in 2022

1. “Immune Checkpoint Inhibitors in Cancer Therapy”
by Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani, Seyed Reza Hosseini-Fard, Shadi Hosseini, Habib Sadeghirad, Rahul Ladwa, Ken O’Byrne and Arutha Kulasinghe
Curr. Oncol. 2022, 29(5), 3044–3060; https://doi.org/10.3390/curroncol29050247
Available online: https://www.mdpi.com/1718-7729/29/5/247

2. “Immunotherapy in Gastric Cancer”
by Anica Högner and Markus Moehler
Curr. Oncol. 2022, 29(3), 1559–1574; https://doi.org/10.3390/curroncol29030131
Available online: https://www.mdpi.com/1718-7729/29/3/131

3. “Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer”
by Valentina K. Todorova, Stephanie D. Byrum, Allen J. Gies, Cade Haynie, Hunter Smith, Nathan S. Reyna and Issam Makhoul
Curr. Oncol. 2022, 29(2), 613–630; https://doi.org/10.3390/curroncol29020055
Available online: https://www.mdpi.com/1718-7729/29/2/55

4. “Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review”
by Samiha Mohsen, Philip T. Sobash, Ghada Fahad Algwaiz, Noor Nasef, Safaa Abed Al-Zeidaneen and Nagla Abdel Karim
Curr. Oncol. 2022, 29(3), 1695–1708; https://doi.org/10.3390/curroncol29030141
Available online: https://www.mdpi.com/1718-7729/29/3/141

5. “Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology”
by Hamid Mithoowani and Michela Febbraro
Curr. Oncol. 2022, 29(3), 1828–1839; https://doi.org/10.3390/curroncol29030150
Available online: https://www.mdpi.com/1718-7729/29/3/150

6. “A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature”
by Adrian J. M. Bailey, Aidan M. Kirkham, Madeline Monaghan, Risa Shorr, C. Arianne Buchan, Christopher Bredeson and David S. Allan
Curr. Oncol. 2022, 29(1), 337–349; https://doi.org/10.3390/curroncol29010030
Available online: https://www.mdpi.com/1718-7729/29/1/30

7. “Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma”
by Qian Zhang, Hanlin Li, Yang Liu, Jian Li, Chunling Wu and Hua Tang
Curr. Oncol. 2022, 29(8), 5383–5406; https://doi.org/10.3390/curroncol29080427
Available online: https://www.mdpi.com/1718-7729/29/8/427

8. “Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence”
by Ilaria Attili, Antonio Passaro, Pasquale Pisapia, Umberto Malapelle and Filippo de Marinis
Curr. Oncol. 2022, 29(1), 255–266; https://doi.org/10.3390/curroncol29010024
Available online: https://www.mdpi.com/1718-7729/29/1/24

9. “Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art”
by Gianluigi Califano, Idir Ouzaid, Paul Laine-Caroff, Arthur Peyrottes, Claudia Collà Ruvolo, Benjamin Pradère, Vincent Elalouf, Vincent Misrai, Jean-François Hermieu, Shahrokh F. Shariat et al.
Curr. Oncol. 2022, 29(2), 687–697; https://doi.org/10.3390/curroncol29020060
Available online: https://www.mdpi.com/1718-7729/29/2/60

10. “Endometrial Cancer: Transitioning from Histology to Genomics”
by Cristina Mitric and Marcus Q. Bernardini
Curr. Oncol. 2022, 29(2), 741–757; https://doi.org/10.3390/curroncol29020063
Available online: https://www.mdpi.com/1718-7729/29/2/63

11. “Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article”
by Chieh-Hsun Chen, Hsin-Su Yu and Sebastian Yu
Curr. Oncol. 2022, 29(4), 2871–2886; https://doi.org/10.3390/curroncol29040234
Available online: https://www.mdpi.com/1718-7729/29/4/234

12. “Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond”
by Maple Ye Feng, Landon L. Chan and Stephen Lam Chan
Curr. Oncol. 2022, 29(8), 5489–5507; https://doi.org/10.3390/curroncol29080434
Available online: https://www.mdpi.com/1718-7729/29/8/434

13. “Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis”
by Salvatore Cozzi, Masoumeh Najafi, Marzieh Gomar, Patrizia Ciammella, Cinzia Iotti, Corrado Iaccarino, Massimo Dominici, Giacomo Pavesi, Chiara Chiavelli, Ali Kazemian et al.
Curr. Oncol. 2022, 29(2), 881–891; https://doi.org/10.3390/curroncol29020075
Available online: https://www.mdpi.com/1718-7729/29/2/75

14. “Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care”
by Brandon S. Sheffield, Andrea Beharry, Joanne Diep, Kirstin Perdrizet, Marco A. J. Iafolla, William Raskin, Shaan Dudani, Mary Anne Brett, Blerta Starova, Brian Olsen et al.
Curr. Oncol. 2022, 29(3), 1326–1334; https://doi.org/10.3390/curroncol29030113
Available online: https://www.mdpi.com/1718-7729/29/3/113

15. “Applications of Artificial Intelligence in Screening, Diagnosis, Treatment, and Prognosis of Colorectal Cancer”
by Hang Qiu, Shuhan Ding, Jianbo Liu, Liya Wang and Xiaodong Wang
Curr. Oncol. 2022, 29(3), 1773–1795; https://doi.org/10.3390/curroncol29030146
Available online: https://www.mdpi.com/1718-7729/29/3/146

More News...
Back to TopTop